Skip to main content
Loading ResearchHub…
Cited by — Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report | ResearchHub - ResearchHub